Production (Stage)
NuGen Medical Devices Inc.
NGMD.V
TSX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 79.07% | 44.44% | 3.48% | -5.73% | -44.33% |
| Total Depreciation and Amortization | -10.37% | -7.91% | -12.69% | -9.11% | -1.65% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -214.76% | -91.00% | -5.70% | -44.07% | -23.68% |
| Change in Net Operating Assets | -205.92% | 61.72% | 1,126.21% | 222.18% | 433.96% |
| Cash from Operations | 16.93% | 31.49% | 44.14% | 37.36% | -74.86% |
| Capital Expenditure | -236.36% | -236.36% | -- | -175.00% | -175.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 97.63% | 96.81% | 96.78% | -- | -- |
| Cash from Investing | 79.30% | 78.39% | 90.88% | -4,950.00% | -4,912.50% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 99.19% | 96.81% | 98.05% | 94.83% | -642.75% |
| Issuance of Common Stock | 66.09% | 40.93% | -89.20% | -70.29% | 106.57% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 88.95% | 55.76% | 50.05% | -66.67% | 85.65% |
| Foreign Exchange rate Adjustments | -- | -- | -- | 148.56% | -23.33% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 13,857.64% | 1,759.38% | 413.86% | -190.89% | 76.25% |